Drug intelligence / Profile preview

Yishen Qufeng

Development stage
Unknown
Lead developer
Jiangsu Provincial Hospital of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Yishen Qufeng is a Traditional Chinese Medicine (TCM) hospital preparation developed by the Jiangsu Provincial Hospital of Chinese Medicine (Affiliated Hospital of Nanjing University of Chinese Medicine). It is specifically indicated for the treatment of diabetic nephropathy (DN) and chronic kidney disease (CKD). The formula is designed based on the TCM therapeutic principle of 'tonifying the kidney and dispelling wind,' addressing the pathogenesis of renal deficiency and the invasion of external or internal 'wind' pathogens that contribute to proteinuria. Clinical and preclinical research suggests that Yishen Qufeng exerts its therapeutic effects by reducing urinary albumin excretion, protecting podocytes from injury, and inhibiting renal fibrosis. These effects are likely mediated through the modulation of the TGF-β1/Smad signaling pathway and the inhibition of inflammatory mediators such as NF-κB.

Brand names
Yishen Qufeng
Other names
Yishen Qufeng formulaYishen Qufeng granulesYishen Qufeng liquidYishen Qufeng Ye
02

Targets

NF-κBTGFB1 (Transforming growth factor Beta-1 proprotein)

Beyond the preview

Go deeper on Yishen Qufeng.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yishen Qufeng.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call